Rebelution

Rebel Medicine is a pharmaceutical company dedicated to transforming acute pain management by developing long-acting, non-opioid therapies. The company leverages proprietary drug delivery technologies to create extended-release formulations of established anesthetics, aiming to reduce the healthcare system's reliance on opioids. Its lead candidate, Alevatrix, is an injectable bupivacaine gel designed to provide 72-96 hours of localized pain relief following surgery. By providing effective, multi-day analgesia, Rebel Medicine seeks to improve patient recovery outcomes and lower costs associated with opioid-related adverse events.